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ABSTRACT
Objectives: Over-the-counter (OTC) pharmacy medicines
are considered relatively safe in contrast to prescribed and
illicit substances, but their abuse and addiction potential is
increasingly recognised. Those affected represent a hard to
reach group, with little known about their experiences.
Study objectives were to describe the experiences and
views of those self-reporting OTC medicine abuse, and why
medicines were taken, how they were obtained and
associated treatment and support sought.
Design: Qualitative study using in-depth mainly telephone
interviews.
Participants: A purposive sample of 25 adults, aged
20–60s, 13 women.
Setting: UK, via two internet support groups.
Results: Individuals considered themselves ‘addicted’, but
socially and economically active and different from illicit
substance misusers. They blamed themselves for losing
control over their medicine use, which usually began for
genuine medical reasons and not experimentation and was
often linked to the cessation of, or ongoing, medical
prescribing. Codeine, in compound analgesics, was the
main medicine implicated with three distinct dose ranges
emerging with decongestant and sedative antihistamine
abuse also being reported. Subsequent use was for the
‘buzz’ or similar effects of the opiate, which was obtained
unproblematically by having lists of pharmacies to visit and
occasionally using internet suppliers. Perceived withdrawal
symptoms were described for all three dose ranges, and
work and health problems were reported with higher
doses. Mixed views about different treatment and support
options emerged with standard drug treatment services
being considered inappropriate for OTC medicines and
concerns that this ‘hidden addiction’ was recorded in
medical notes. Most supported the continued availability of
OTC medicines with appropriate addiction warnings.
Conclusions: Greater awareness of the addiction potential
of OTC medicines is needed for the public, pharmacists
and medical prescribers, along with appropriate
communication about, and reviews of, treatment and
support options, for this distinct group.
INTRODUCTION
In contrast to prescribed and illicit drugs,
those available for individuals to purchase
legally without prescription have often been
perceived by the public to be relatively safe.1 2
Such non-prescription, or over-the-counter
(OTC) medicines as they are also known, are
typically those purchased from non-medical
outlets such as pharmacies and increasingly
the internet3 and have enabled individuals to
be active participants in their own health.4
There has been increasing concern, however,
about the potential for OTC medicines to
cause harm, as a recent All Party Parliamentary
report,5 and a joint consensus statement6 on
addiction to medicines in the UK illustrate.
Implicated medicines and therapeutic groups
include stimulants, laxatives, sedatives, dissocia-
tive substances and opiate-containing medi-
cines such as codeine.7 8 There has been
increased reporting of harms associated with
codeine addiction and particularly from side
effects of additional ingredients, such as ibu-
profen and paracetamol which have led to
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fatalities.7 9 These have resulted in regulatory changes in
countries such as the UK10 and Australia involving
restricted indications and addiction warnings on codeine-
containing analgesic packets.
Despite these emerging concerns, the scale of the
problem remains uncertain and very little is known
about the characteristics and particularly the experi-
ences of those affected.7 11 Empirical quantitative
studies have provided some evidence suggesting that a
diverse group of individuals may be affected, ranging
from adolescents experimenting with cough medicines
in the USA,12 to older individuals abusing analgesics in
Nigeria,13 and abuse of codeine-containing medicines
and sedatives involving ‘middle-aged females’ in the
UK.14 15 Such individuals have been recognised as a
hard to reach group5 and this has resulted in indirect
attempts to describe those affected, such as seeking
pharmacists’ proxy views of those affected through
surveys.7 16 This paper describes the ﬁndings of a study
that sought to explore the views and experiences of indi-
viduals who considered themselves affected by OTC
medicine addiction in the UK, to understand how it
arose, what medicines were implicated and how they
were obtained and what forms of treatment and support
were used.
METHODS
A qualitative methodology—neglected to date in this
area—was adopted for this study, which represented part
of a larger overall study that included stakeholders and
pharmacy staff17—using semistructured in-depth mainly
telephone interviews. Purposive sampling was used,
based on a review of the literature,7 to ensure that a
range of ages, gender, medicines used, reasons for initial
use (genuine or experimental) and treatment and
support options were represented. Individuals describing
only prescribed medicines were excluded and since the
aim was to capture self-perception of OTC medicine
addiction, a dependency screening measure was not con-
sidered appropriate.18 Recruitment was undertaken via
two internet-based support groups for those affected
—‘Overcount’ and ‘Codeinefree’. A total of 25 inter-
views were undertaken (see table 1) over an 18-month
period between 2009 and 2010, reﬂecting a slow uptake
to participate. This was considered to be related to the
hard to reach nature of this group, and prospective par-
ticipants often made initial contact to discuss provisions
for remaining anonymous in the study. The ﬁnal sample
size was determined by theoretical saturation being
achieved in emergent themes. An interview schedule
was developed based on a review of the literature7 and
since recruitment occurred both before and after addic-
tion warnings were introduced in the UK, participants
were either asked for their views about warnings in
general or their experiences or views of the actual
change, respectively.10 Interviews were conducted by
telephone in all but two cases, and were digitally audio
recorded and then fully transcribed and anonymised.
Analysis of transcripts involved an initial process of open
coding, which was also informed by the themes from the
available literature7 and the interview schedule. Axial
coding between participant transcripts was then under-
taken using the constant comparison process which
involved reading and re-reading transcripts to identify
links between emerging codes and participants and
their characteristics. A ﬁnal process of further reﬁning
of themes was undertaken until these provided explana-
tory accounts of the data. University ethical approval was
obtained.
RESULTS
Analysis of interviews revealed three broad, chrono-
logical themes: initial use of the medicine, often linked
to genuine medical reasons; awareness of a problem
with the medicine over time, with three distinct groups
of dose levels being apparent, and ﬁnally attempts to
seek treatment and help, which were associated with
varying degrees of success. All participants described
having a problem with an opiate (codeine and occasion-
ally dihydrocodeine), although the stimulant decongest-
ant pseudoephedrine and sedative antihistamines in
sleeping medicines or cold remedies were also referred
to by some. However, spanning these themes was also a
dominant concern relating to the hidden nature of OTC
medicine addiction and of participant’s presentation of
themselves as being normal and distinct from those with
other, illicit addictions. This theme will be described
along with other themes related to the unproblematic
nature of obtaining medicines and views about regula-
tion and responsibility.
Initial use of OTC medicines
Genuine medical reasons were almost always associated
with the initial use of an OTC medicine and due to the
involvement of codeine for almost all of these patients;
there was not an unexpected range of pain-related symp-
toms or conditions, including headaches and migraine,
abdominal and period pain and hangover treatments.
Of note was that there was often an association with
medically prescribed medicines, either through initial
prescribing that had then stopped or on-going prescrib-
ing (ﬁgure 1):
I mean my story started by being on painkillers for gynae-
cological problems and that was when I ﬁrst took
codeine [...] Then I found when I couldn’t get codeine
on prescription any longer it was readily available over
the counter. P9
Participants using both prescribed and OTC medi-
cines described either using OTC medicines to cover
gaps before a new prescription started, or to allow the
strength of medicine used to be varied. In contract, two
participants described intentionally experimenting with
an OTC medicine—pseudoephedrine and codeine—
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Table 1 Participant details
Participant Sex Age Employment Product Dose(s) used
Use of medicine at
time of study?
Treatment(s) and
support used
1 F 40s Housewife Solpadeine+diverted Solpadol Varied, up to 12–13/day II No ‘Cold turkey’, CF
website
2 F 60s Professional Nurofen Plus No more than 6/day I No CF
3 M 40s Unemployed Paramol, alcohol and Sudafed for
short period
Up to 36/day either 16+16 or 12
+12+12 III
No GP, DAAT (methadone),
Overcount
4 M ND Professional Co-codamol, then Syndol Up to 8/day I Yes GP, CF
5 M 30s Professional Co-codamol 12–14/day II Yes CF
6 M 30s Professional
self-employed
Nurofen Plus+prev. non-opiate illicit
substances
Max of 60 tablets/day III No GP, DAAT
(buprenorphine) CF
7 F ND Former healthcare
professional
Solpadeine Up to 8/day I No CF
8 F ND Co-codamol soluble+prescription
co-codamol 30/500
Up to 16/day (max 4/dose) II No CFM
9 F ND Healthcare
professional
Nurofen Plus 32/day (very occ. 64/day) III No CF+buprenorphine
10 F 30s University student Feminax then Cuprofen Plus prev.
alcohol
36/day III Yes CF
11 F 40s Professional Nurofen Plus 24/day III No CF
12 F 20s Professional Co-codamol+prescribed Up to 8/day I No CF
13 F ND Professional Co-codamol+prescribed up to 16/day occasionally
+prescribed II
Yes GP, Overcount
14 M 50s Retired professional Nurofen Plus+prescribed codeine
phosphate
10/day Nurofen plus+MDD of
codeine III
No Overcount
15 M 60s Professional Solpadeine soluble very occasionally 10/day II No Private treatment
16 M ND Professional Phensedyl 90 bottles/week III No GP, DAAT
17 M ND Professional Panadol Ultra and Nurofen Plus 15–20 of each III No GP
18 M ND ND Solpadeine 4/day I No Overcount
19 M ND Self-employed Nurofen Plus 10/day II Yes CF, DAAT, GP
20 F ND ND Solpadeine Up to 8/day I Yes Overcount
21 F ND ND Syndol Up to 8/day I Yes CF, GP
22 M ND Former healthcare
professional
Codeine linctus, Gees linctus,
stolen dihydrocodiene
Varied but much above max
daily dose. III
No CF+DAAT (methadone)
23 M 60s Retired professional Phensedyl, actifed, codeine linctus
diverted prescription codeine
200 mL codeine linctus/day III No CF+GP+DAAT
(methadone)
24 F 30s Professional Syndol+Nytol Syndol: prev. up to 8/day, now
12/day in last 12 months II
Yes Syndol Overcount
25 F 50s Professional Feminax, then Veganin 6–10/day. Max=12/day II Yes Overcount+GP+drug
action
I, consuming less than maximum recommended dose; II, consuming slightly higher than maximum recommended doses; III, consuming significantly higher than maximum recommended doses;
CF, CodeineFree (internet support); DAAT, drug and alcohol treatment; F, female; GP, general practitioner (doctor); M, male; ND, not disclosed; Overcount, Internet support.
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having been told about their abuse potential by others
(see ﬁgure 2).
For all those participants who described a genuine
initial use of a product, this led eventually to the medicine
being taken for different reasons. The key reason cited
related to codeine and while the effect varied, common
phrases used were the ‘buzz’ or ‘calm’ associated with its
use, although exploiting sedative side effects were also
reported by some:
I remember when I took them that it would give you a
lift and a buzz, but that lift or buzz would go and the
only way to sustain that is to take more. P11
Pseudoephedrine was associated with its
stimulant-related side effects and antihistamines like
diphenhydramine were used to promote sleep.
Participants reﬂected that abused medicines and par-
ticularly codeine allowed them to cope, particularly with
signiﬁcant life events such as bereavements, work or rela-
tionship problems.
Obtaining medicines
Participants all described the use of pharmacies to
obtain supplies and two also described using internet
pharmacies. A key feature of both was how unproblem-
atic it was to obtain medicines, with policies to restrict
supplies being perceived to be ineffective, and some
pharmacies were considered easier than others to obtain
supplies (box 1).
Avoiding detection was a key concern for individuals
who described intentionally varying the pharmacy used,
using ‘schedules, ‘tables’ or ‘lists’ of those visited and
lying and fabricating responses to questions from staff:
I had to go to different pharmacies and I didn’t want to
get knocked back. I would go in and I would make out
that I had a toothache, so I didn’t know the best thing. I
wouldn’t directly ask for the product, because I know
that was suspicious. P10
Most participants did recall isolated and uncomfort-
able instances of being challenged; in some cases, result-
ing in avoiding that pharmacy or visiting less:
I’ve only ever been challenged once and it was quite a
confrontational challenge and…but that was back in the
days when I was taking eight a day and […] that one
experience kind of altered how I did things. I started
pharmacy shopping, I started varying where I went and I
started to notice you know the shop workers’ routines.
P18
However, several participants considered these chal-
lenges to have inﬂuenced their attempts to seek help:
I knew it would come sometime but you know to actually
face it, that she had actually confronted me with it and
that was really a wakeup call for me. P19
Internet pharmacy purchases were mentioned by two
participants, who reported being able to obtain multiple
quantities repeatedly. Although policies varied between
suppliers, questionnaires or identiﬁcation checks were
recognised as being mechanisms that were intended to
limit supplies, but which could be easily circumvented.
Other participants were cautious of internet medicine
supplies and expressed concerns about the lack of safety
of such supplies.
Awareness of a problem
The second key chronological theme involved partici-
pants becoming aware of having a problem. Strikingly,
the words ‘addiction’ or ‘addicted’ were frequently spon-
taneously used by participants to describe themselves
and their situation. Awareness of a problem centred
mainly on perceived withdrawal symptoms, although
awareness of prolonged consumption over time, critical
incidents and a perceived loss of control generally were
also identiﬁed. Anxiety, generalised pain or headache
and gastrointestinal problems were variously described
and attributed to the medicine having been stopped:
Yeah I am an addict, no doubt about it. As much as a
heroin addict, yeah. Shameful and it makes you feel dirty
and guilty, but I was an addict, yeah. Well I have stopped
taking codeine before and for the past few days I have
had cold sweats and had palpitations and had withdrawal
symptoms. So the physical symptoms suggest that I am
addicted to it and also the psychological. P10
Critical incidents such as rare instances of being con-
fronted in a pharmacy, medical problem such as a
gastrointestinal bleed or illegal activity also appeared to
represent moments when participants considered
Figure 1 Relationship between over-the-counter medicine
use and prescribed medicines.
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themselves to have a problem. A recurrent theme
involved participants’ perceived loss of control over their
medicine consumption, either gradually and suddenly
and several participants expressed disbelief that addic-
tion could have happened to them, and often drew
upon professional, educational status or intelligence
claims to argue that they should have had the under-
standing or insight to prevent this happening.
The role of the two internet support forums—particularly
in postings of other individual’s descriptions—appeared to
be conﬁrmatory of their problem and participants’ use of
words like ‘addiction’ and ‘rebound headache’ appeared to
have originated from here. Several argued that genetic
factors—in references to family members with addictions—
might explain their OTC medicine addiction, and several
felt that their personality and previous problems—with
alcohol misuse for example—were explanatory. In these
accounts, participants made explicit and sustained attempts
to distinguish themselves from individuals with other addic-
tions and particularly illicit substance users, who they viewed
more negatively in both a behavioural and visual sense:
Addicts are people on the street who haven’t got a job
and I am sat here in a suit in an ofﬁce, my own ofﬁce
with a very good career, senior manager within a very
large organisation and I can’t be an addict. I am. P5
A respectable appearance, good employment status
and education were often cited as reasons why partici-
pants were different, although there was also recognition
that their addiction was ultimately the same.
Figure 2 Summary of different initial use, types of use and treatment.
Box 1 Reasons why pharmacy purchases were consid-
ered unproblematic
▸ Many participants, and especially those taking higher doses,
varied where they made purchases.
▸ A number of different pharmacies were often located in prox-
imity to participants.
▸ Pharmacy staff often asked questions but seldom challenged
participants.
▸ Participants provided responses to pharmacy staff questions
that would not lead to challenges.
▸ Occasional references were made to pharmacies that sold mul-
tiple packs.
▸ Participants, such as those taking doses less than the
maximum, did not need to visit pharmacies often.
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Three types of OTC medicine abuse
A distinction was evident between participants based
upon the quantities of medicines taken, with three types
emerging (ﬁgure 2) which were relative to the recom-
mended maximum doses of speciﬁc products. A ﬁrst
group was characterised by self-reported use that never
exceeded the recommended maximum dose of a medi-
cine. A second type involved daily doses slightly above
the maximum recommended dosage and often involving
paracetamol and codeine (500 mg and 8 mg/tablet,
respectively) compound analgesics formulations and this
occurred sometimes due to combinations of OTC and
prescribed medicines. In both these groups, there was
awareness of the harms associated with the medicine,
and use for non-therapeutic reasons and perceived with-
drawal. Such participants often explicitly defended their
addiction status, despite the relatively low doses, and
appeared aware—usually from posts on internet support
groups—of individuals taking much higher doses. Such
higher doses represented the third type of consumption
identiﬁed in this study and was characterised by doses
much higher than recommended, with those describing
codeine and ibuprofen (12.8 mg and 200 mg/tablet,
respectively) compound tablet use, for example, report-
ing daily consumption between 32 and 64 tablets:
[…] I would take eight in one day. But then of course in
increasing amounts. Till the point came that I was taking
thirty two a day. Even on really bad days, I would take a
second lot of thirty two. P9
Distinct to this group was that three participants had
described criminal activity relating to their addiction—
convictions for theft being mentioned in two cases—and
this group alone was associated with descriptions of sig-
niﬁcant health problems, including gastric bleeding and
hospitalisation following organ damage; signiﬁcant pur-
chasing costs were also associated with this group.
However, despite these more signiﬁcant issues, this
group similarly differentiated themselves from those
with other forms of addiction and in two cases referred
to their healthcare professional backgrounds to support
their claims.
A ‘hidden’ addiction
In describing their situations, individuals often made
overt attempts to keep their problem hidden, and this
occurred particularly at work where concerns about a
perceived change in appearance or behaviour were
thought likely to arouse suspicions among colleagues.
Of note was that it was the change in appearance that
worried participants primarily, and not being seen
taking a medicine, which was considered by them to be
an everyday activity which would not arouse suspicion in
itself. Keeping medicine abuse hidden from family and
home environments was also identiﬁed, although for a
minority, friends and family were aware and had pro-
vided support. Many participants also referred to the
inﬂuence of OTC abuse on their family and relation-
ships more generally, with a tension being apparent in
trying to keep OTC addiction secret, but recognising the
support that others could offer. For some, family and
friends were viewed positively and provided support
when a participant was trying to seek treatment, but in
other cases much less so
To be honest, I can’t discuss it with my family. They
simply wouldn’t understand. It would be a horror for
them. And they don’t deal with things like that very well,
at all. P6
Treatment and support
The third main chronological theme concerned subse-
quent attempts by all individuals to address their OTC
medicine addiction. These varied considerably and
appeared in part related to the quantities of medicine
taken (box 1) and included internet support group help
in all cases, as well as National Health Service (NHS)
medical general practitioner (GP) consultations, special-
ist NHS drug and alcohol treatment services, a private
clinic, counselling, self-management and narcotics
anonymous (see ﬁgure 2). Perceived beneﬁts of these
varied, with initial self-treatment, for example, often
being considered ineffective and there was a view that
several services, particularly narcotics anonymous and
specialist drug services, were not suited to OTC medi-
cine addiction. Participants’ need for anonymity was
again evident, with concerns being expressed about
addiction being recorded in medical notes and employ-
ers and others becoming aware; this extended to the
intentional use of pseudonyms by participants on inter-
net support groups. Of note was that pharmacists were
not referred to at all in relation to treatment and
support.
GP involvement led to both positive and negative com-
ments although some participants had speciﬁcally not
sought GP advice, due either to poor existing relation-
ships or, linked to the hidden nature of this issue, con-
cerns about their addiction being recorded. Many
participants felt that their doctor considered OTC medi-
cine addiction to be less serious than other addictions
and something not to be concerned about or suited to
simple self-management:
[…] I have mentioned it to the doctor and he sort of
said, ‘well it’s something you handle yourself’. At this sort
of level […] P19
Some GPs had attempted to treat, although experi-
ences suggested this was not successful:
[…] my GP, he tried to detox me with the dihydroco-
deine […] I just ended up taking the tablets over a week,
you know, that was failure you know. P3
More positively, others described being referred by
their GP to specialist drug and alcohol services, and
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these were associated most often with those taking con-
siderably higher doses of medicine and occurred also
from self-referrals and court orders. The overwhelming
experience for all participants was that such services were
not set up to accommodate those with OTC addiction
and several factors were evident. The mixing of clients
with different addictions was considered a problem, and
there was a perception that staff viewed OTC addiction as
a lesser problem, and also lacked experience:
‘I have got a problem with being addicted to
co-codomol’. They thought I was being a bit stupid. I
think they thought that you know that I should just with-
draw slowly. P13
Treatment options involving speciﬁc medicines were
also viewed problematically, mainly due to their associ-
ation with illicit drug treatment or having supervised
consumption:
I was turning up to [local] drug unit for my daily dose of
methadone as though I was a heroin addict […] At that
stage, I didn’t think that methadone was appropriate. P22
However, the accounts provided from those consum-
ing more signiﬁcant amounts of opiates suggested that
such services, and the use of buprenorphine and metha-
done, often led to positive outcomes—either on main-
tenance doses or opiate free—even if concerns were
initially apparent about such treatments being inappro-
priate and suited only for illicit substance misusers.
Self-treatment was often something considered as a
ﬁrst stage, when awareness of a problem had occurred,
but it was also attempted as a response to guidance and
support from internet support groups. Participants
described either stopping completely or reducing the
dose gradually:
I went cold turkey as they say. I was on my own in our
place […] and I decided that I’d had enough of basically
the rounds of going to the doctors and getting the stuff,
having problems maybe getting the stuff and then going
to different chemists. P14
The two online support groups—Overcount and
Codeinefree—appeared to be particularly relevant in
attempts to self-treat, and appeared to have been found
during general searches of the internet for information
about their addiction. The two websites were perhaps
the most positively received of all the options available
to participants based on their experiences, and provided
treatment options, including speciﬁc advice with direct
communication from website staff and participants and
also generic information on the websites and from
other’s posts. The websites offered a positive conﬁrma-
tory function for many, as when one participant (P25)
noted, ‘there are many more in the same boat, going
through the same struggle’ although participants’ level
of engagement with the sites varied considerably and
while some continued to actively interact, other stopped
after the initial conﬁrmatory aspect.
Responsibility and regulation
All participants were asked for their views on how OTC
addiction could be prevented, and issues were identiﬁed
in terms of the overall availability of OTC medicines, the
use of information and particularly addiction warnings
and the balance between professional and personal
responsibility. Of note was that most participants were in
favour of the continued availability of OTC medicines
with addiction potential and often blamed themselves
for their situation. Convenient access to medicines was
often argued to outweigh the addiction risks to a minor-
ity, and this view was advanced irrespective of the level of
consumption by participants:
Everyone should have a choice what they do with their
life—as long as they have the awareness of the danger
then it’s up to each individual what they do with that
information and what path they choose. P25
Analogies were drawn by several to the current avail-
ability of other substances that can cause addiction, like
tobacco and alcohol, and that their continued availabil-
ity supported the availability of OTC medicines. A
minority felt that the need to avoid harm was paramount
and advocated prescription-only availability, although
recognising that this may increase doctors’ workloads
and NHS costs. The addition of addiction warnings to
packets was considered relevant only to those not
already addicted:
So I mean it is better than nothing certainly to have a
warning on the packet […] and it will put some people
off, but the people who need to be put off, I am not sure
it would. P14
This view was held by those interviewed both before
and after the addiction warnings were introduced and
for those still taking OTC medicines at the time of the
study, there was a lack of awareness, which one partici-
pant (P5) summed up as ‘I’ve not noticed, but then
again I’m not looking’. There was little awareness of
regulatory changes relating to pack sizes in the UK from
those interviewed after the changes, but a view that, like
warnings, these may have some beneﬁt, but only to
those who did not already have a problem.
Participants spontaneously raised the issues of respon-
sibility and most felt that they were responsible as indivi-
duals, and had decided to use the medicine and should
have noticed changes in use. This was often linked to
assertions by the participant that they were intelligent
and a recurrent theme was the claim that they were con-
trolled individuals, often with successful jobs and gradu-
ate and postgraduate university qualiﬁcations, and for
whom OTC addiction was in some respects atypical:
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You know I am not an unintelligent fellow and I have got
access to the internet like everybody else. I knew what
the consequences were, but I still couldn’t stop it. P14
While other factors may have been contributory for a
minority—such as pharmacies who continued to supply,
or a GP who prescribed inappropriately in one case or
post-perative care which did not address analgesic needs
—it was ultimately considered a personal cause and
resultant problem.
DISCUSSION
Main findings, strengths and weaknesses
The main ﬁndings of this study are that perceived OTC
medicine addiction arises from often genuine medical
reasons linked to prescribing rather than experimenta-
tion, and that obtaining medicines appeared unproblem-
atic and treatment options vary in perceived suitability
and success. The strength of the study was the use of sam-
pling via internet support groups that enabled the
recruitment of a recognised hard to reach group and to
allow them to present their experiences in depth in a
qualitative empirical study. However, related study limita-
tions are that the sample reﬂected only those individuals
who had internet access and already recognised that they
had a problem and that those who had not engaged with
these support groups were not represented. In addition,
the dominance of codeine among participants may be
related to one of the internet support groups targeting
only those affected by opiates. Only UK perspectives were
presented, although the range of medicines, pharmacy-
based supplies and regulations in the UK are broadly
similar to those found in many other countries across
Europe and also Australia. Analysis of interviews solely by
the researcher and hence without either participant or
other researcher validation or coding, respectively, repre-
sents a further study limitation.
Relevance to existing literature and implications of results
The study provides further evidence that several medi-
cines—opiates, stimulants and sedatives7 8—are impli-
cated in OTC medicine abuse and while illustrating the
primacy of codeine as a concern, also highlights that
other medicines are abused for non-therapeutic effects.
It also indicates that problems can occur in a range of
doses, and supports previous research in Australia18 that
found both high and low dose dependency although
there was less evidence of experimental or recreational
use in the present study. The ﬁndings suggest that there
is a need to raise awareness about the possibility of OTC
medicine addiction, not only for prevention but also
treatment and support. While previous research has sug-
gested awareness among the public about the abuse
potential of medicines, this may reﬂect terminological
confusion over misuse rather than addiction potential19
and so alerting the public to the potential for addiction
is necessary, such as through warnings on packets.
Raising awareness amongst doctors who prescribe medi-
cines initially is important, since this study suggests that
the cessation of prescribed medicines or more complex
patterns of concomitant use of prescribed and OTC
medicines may be associated with OTC medicine addic-
tion. This, again, reﬂected often genuine reasons for
initial OTC medicine use rather than intentional experi-
mentation. Research has suggested a high level of aware-
ness of OTC medicine abuse potential among GPs but
also the need for more training20 and this may be neces-
sary given other concerns that doctors seldom question
patient’s self-treatment and use of OTC medicines.21
Raising awareness of the distinct nature and concerns of
this group is also needed for other healthcare profes-
sionals, such as those in addiction services, given con-
cerns in this study, and the literature15 as to the
appropriateness of some services. This also applies to
pharmacists and particularly since research suggests that
they may experience uncertainty about how to support
those affected17 This study offers suggestions about pos-
sible questions for healthcare professionals such as phar-
macists and prescribers, particularly in relation to
individuals experiencing more severe self-reported pro-
blems. For example, asking if individuals had ever taken
more than the recommended maximum dose, if their
medicine use had affected their work or social life, or if
they felt they had lost control over their medicine use
have all emerged from this study. However, it is also of
note that pharmacists were not referred to by partici-
pants at all in relation to treatment or support in the
present study, and this not only reﬂects previous omis-
sions in the literature5 but also concerns around difﬁcul-
ties in implementing harm-reduction strategies in this
setting.7 11 22
Emerging problems for practice
The results of this study reveal a number of tensions that
may be problematic in supporting those affected and
preventing addiction to medicine. The ﬁrst involves rec-
onciling individuals’ self-perception of addiction and the
need for associated support with doses taken since of
the three types of consumption identiﬁed, those never
exceeding the maximum dose, for example, may have a
much lower risk of harm and existing opiate addiction
treatments may be clinically inappropriate. This is not to
suggest that there are not genuine problems in all three
types of consumption identiﬁed, and the qualitative
nature of this study has revealed detailed accounts of a
range of negative experiences of OTC addiction, with
issues of shame and adverse effects on health, work and
relationships, for example, which are recognised in the
wider addiction literature.23 Subtherapeutic dependence
has also emerged in other OTC medicine research,18
but such use may arguably also be related to a more per-
ceived loss of control than to therapeutic depend-
ency.18 24 A further and related tension arises in the
inﬂuence of the internet support groups; while being
viewed positively overall and offering important support
8 Cooper RJ. BMJ Open 2013;3:e002913. doi:10.1136/bmjopen-2013-002913
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and treatment advice, this study suggests that they may
contribute to a perception in some individuals that they
are addicted, even at low doses. This potential widening
of the types of addiction in society is an increasing
concern25 and one which may also threaten the previous
aim of raising awareness among doctors, since this may
suggest a wider range of affected patients than might
actually require identiﬁcation and referral for treatment.
A tension also arises in participants’ perception that
they are different from those with other addictions and
that treatments are not appropriate, and trying to recon-
cile this with participants’ insight that they have a
problem and that existing treatments appear to be effect-
ive in some cases. This will require a consideration about
how such treatments and services are presented and com-
municated to individuals, in a way that recognises partici-
pants’ anxieties about reporting in medical records and
keeping their addiction hidden. There are parallels in
this respect with addiction to prescribed medicines and
of how to support those affected by these too. A ﬁnal
tension centres on making OTC medicines of potential
abuse available to the public—which almost all partici-
pants supported—while recognising the potential harms
for some individuals. This conﬁrms the importance of
choice and recognition moreover of a person who ‘wants
autonomy and freedom to choose such medicines’.26
CONCLUSIONS
A range of problems have emerged from individuals
who experienced addiction to OTC medicines, with dis-
tinct dose ranges emerging through often genuine
initial reasons for use, via often unproblematic supplies
from pharmacies and occasionally the internet, with
medical prescribing being associated in many cases.
Current treatment and support was not perceived appro-
priate, and those affected considered themselves differ-
ent to others with addiction problems. Raising awareness
about OTC medicine addiction is needed for the public
and also healthcare professionals; providing and com-
municating treatment options that are sensitive to those
affected are needed.
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